With the help of prescription medications and a whole lot of moisturizing, it’s possible to keep dermatitis under control.

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

Zabalafin Hydrogel holds potential for first comprehensive AD treatment with safety and patient tolerability profile for long-term, worry-free, continuous use "This is an incredibly important ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Treating eczema starts with a solid skincare routine, but you may need more than just moisturizer to get you through a ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

—Psychologists rarely participate in the treatment of atopic dermatitis, but this recent study examined the effects of a self-guided intervention for people with AD. How did it compare to ...

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...

If someone has atopic dermatitis during childhood, it’s likely they’ll have recurrent flares and need recurrent treatment. However, parents can help minimize their child’s flares by ...